)
)
)
Tessera Therapeutics
March 02, 2026
Ballroom I C
Type: Company Presentation
Focus Area:
Multiple Therapeutics
Tessera Therapeutics is pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Our mission is to cure disease by writing in the code of life.
Year Founded:
2018
Lead Product in Development:
In vivo gene editing of alpha-1 antitrypsin deficiency (AATD).
Speakers
.jpg)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
